Please use this identifier to cite or link to this item:
Title: SOX7 is down-regulated in lung cancer
Authors: Hayano, T.
Garg, M.
Yin, D.
Sudo, M.
Kawamata, N.
Shi, S.
Chien, W. 
Ding, L.-W. 
Leong, G.
Mori, S.
Xie, D.
Tan, P. 
Koeffler, H.P.
Keywords: CNAG
Lung cancer
Promoter methylation
Issue Date: 2013
Citation: Hayano, T., Garg, M., Yin, D., Sudo, M., Kawamata, N., Shi, S., Chien, W., Ding, L.-W., Leong, G., Mori, S., Xie, D., Tan, P., Koeffler, H.P. (2013). SOX7 is down-regulated in lung cancer. Journal of Experimental and Clinical Cancer Research 32 (1) : -. ScholarBank@NUS Repository.
Abstract: Background: SOX7 is a transcription factor belonging to the SOX family. Its role in lung cancer is unknown. Methods. In this study, whole genomic copy number analysis was performed on a series of non-small cell lung cancer (NSCLC) cell lines and samples from individuals with epidermal growth factor receptor (EGFR) mutations using a SNP-Chip platform. SOX7 was measured in NSCLC samples and cell lines, and forced expressed in one of these lines. Results: A notable surprise was that the numerous copy number (CN) changes observed in samples of Asian, non-smoking EGFR mutant NSCLC were nearly the same as those CN alterations seen in a large collection of NSCLC from The Cancer Genome Atlas which is presumably composed of predominantly Caucasians who often smoked. However, four regions had CN changes fairly unique to the Asian EGFR mutant group. We also examined CN changes in NSCLC lines. The SOX7 gene was homozygously deleted in one (HCC2935) of 10 NSCLC cell lines and heterozygously deleted in two other NSCLC lines. Expression of SOX7 was significantly downregulated in NSCLC cell lines (8/10, 80%) and a large collection of NSCLC samples compared to matched normal lung (57/62, 92%, p= 0.0006). Forced-expression of SOX7 in NSCLC cell lines markedly reduced their cell growth and enhanced their apoptosis. Conclusion: These data suggest that SOX7 is a novel tumor suppressor gene silenced in the majority of NSCLC samples. © 2013 Hayano et al.; licensee BioMed Central Ltd.
Source Title: Journal of Experimental and Clinical Cancer Research
ISSN: 17569966
DOI: 10.1186/1756-9966-32-17
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.


checked on Mar 26, 2020


checked on Mar 18, 2020

Page view(s)

checked on Mar 22, 2020

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.